Pearl River Capital’s Bristol-Myers Squibb BMY Stock Holding History

Pearl River Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,395	Closed	-$764K	–	53
2024 Q2	$764K	Buy	+18,395	New	+$823K	0.12%	219
2024 Q1	–	Sell	-61,801	Closed	-$3.17M	–	479
2023 Q4	$3.17M	Buy	+61,801	New	+$3.24M	0.51%	44
2023 Q3	–	Sell	-17,051	Closed	-$1.09M	–	498
2023 Q2	$1.09M	Sell	17,051 -6,161	-27%	-$413K	0.18%	185
2023 Q1	$1.61M	Sell	23,212 -88,344	-79%	-$6.23M	0.26%	121
2022 Q4	$8.03M	Buy	+111,556	New	+$8.41M	1.36%	2
2022 Q1	–	Sell	-24,483	Closed	-$1.53M	–	407
2021 Q4	$1.53M	Sell	24,483 -49,049	-67%	-$2.88M	0.41%	67
2021 Q3	$4.35M	Buy	73,532 +68,655	+1,408%	+$4.52M	1.18%	8
2021 Q2	$326K	Buy	+4,877	New	+$318K	0.09%	307
2021 Q1	–	Sell	-13,170	Closed	-$817K	–	396
2020 Q4	$817K	Buy	+13,170	New	+$810K	0.29%	119
2020 Q2	–	Sell	-6,658	Closed	-$371K	–	311
2020 Q1	$371K	Buy	6,658 +1,825	+38%	+$112K	0.72%	29
2019 Q4	$310K	Buy	+4,833	New	+$277K	0.12%	327
2019 Q3	–	Sell	-2,647	Closed	-$120K	–	425
2019 Q2	$120K	Sell	2,647 -2,577	-49%	-$120K	0.77%	55
2019 Q1	$250K	Buy	+5,224	New	+$260K	0.62%	16

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pearl River Capital's BMY Position: Q3 2024 in Review

Pearl River Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 18,395 shares — an estimated $764K sold.

Pearl River Capital first reported a position in BMY in Q1 2019 and held it in 13 quarters. The position peaked at $8.03M in Q4 2022. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Pearl River Capital reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
Pearl River Capital sold 18,395 Bristol-Myers Squibb shares in Q3 2024, an estimated $764K.
Pearl River Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 13 quarters.
Pearl River Capital's Bristol-Myers Squibb position peaked at $8.03M in Q4 2022.
2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Pearl River Capital's 13F filing for Q3 2024.